NBY NovaBay Pharmaceuticals leadership outlines new clinical and commercial priorities following its latest quarterly earnings release Duke Energy Corporation DUK PreEarnings Analysis Favorable Odds of Q1 2026 EPS Beat Amid Defensive Sector Tailwinds Is Reading International RDI stock nearing key resistance Q3 2025 Earnings Underperform What favorite stocks Hims HIMS Declines 20260429 SUPV Grupo reports significantly wider Q4 2025 loss than expected shares post small gain FN Fabrinet posts narrow Q1 2026 EPS beat sending shares 446 percent higher in todays trading Best Buy Co Inc BBY CEO Transition Sparks ShortTerm Volatility Amid Bullish LongTerm Consumer Electronics Fundamentals KALV KalVista Pharmaceuticals posts 291 Q4 2025 EPS surprise shares dip marginally in daily trading